Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer

Clinical trial NCT07458529 · RECRUITING

Trial details

NCT number: NCT07458529
Sponsor: Seventh Medical Center of PLA General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Cancer, Adenocarcinoma Neoadjuvant Therapy Immunotherapy Probio-M9 Tislelizumab Randomized

Start date: 2026-02-10
Primary completion: 2027-05-05
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.